Member directory

IE is innovative education that makes an impact. We prepare students for the world today and the world of tomorrow, providing them with the relevant knowledge and skills they need to succeed. IE offers a technology-based learning ecosystem, training the leaders of tomorrow to make positive change through innovation, global vision, an entrepreneurial mindset and a unique focus on the humanities.

IMD is an independent business school with Swiss roots and global reach. Since its creation, IMD has been a pioneering force in developing leaders who transform organizations and contribute to society. Based in Switzerland and Singapore, IMD has been ranked in the Top 3 of the annual FT’s Executive Education Global Ranking for the last nine consecutive years and in the top five for 17 consecutive years. This consistency at the forefront of its industry is grounded in IMD’s unique approach to creating “Real Learning. Real Impact”. Led by an expert and diverse faculty, IMD strives to be the trusted learning partner of choice for ambitious individuals and organizations worldwide. Challenging what is and inspiring what could be.

ING Wholesale Banking (WB) meets all banking needs of large corporations, multinationals and financial institutions. With a history that stretches back some 200 years, we have made a name for ourselves by helping clients build successful businesses. We do this by ensuring we understand their unique needs, by being a trusted advisor to them for the long term and by proactively creating innovative solutions and executing them flawlessly. In addition to the basic banking services of lending, payments & cash management and treasury, we provide tailored banking solutions in areas including corporate finance, leasing, structured finance, commercial finance (factoring), equity markets and debt capital markets. In short, we can finance growth, manage the day-to-day banking needs of our clients and provide them with a full range of banking solutions to help to achieve their business goals. We are a truly international team of more than 11,000 banking professionals with local knowledge and a presence in more than 40 countries.

As one of the world's leading and largest graduate business schools, INSEAD offers participants a truly global educational experience. With campuses in Europe (France), Asia (Singapore) and Middle East (Abu Dhabi), and alliances with top institutions, INSEAD's business education and research spans around the globe. Our 154 renowned faculty members from 40 countries inspire more than 1,400 students in our degree and PhD programmes. In addition, more than 11,000 executives participate in INSEAD's executive education programmes each year.

Certified by the French Ministry of National Education and bound by a convention to the French government, the "International French School (Singapore)" provides a formal education not only to French students residing in Singapore, but also to students of all nationalities who are not French-speakers.

Intertrust is a global leader in providing tech-enabled corporate, capital markets and fund solutions to clients operating and investing in the international business environment. The Company has more than 3,500 employees across 30 jurisdictions in Europe, the Americas, Asia Pacific and the Middle-East. Intertrust has leading market positions in selected key financial markets, including the Netherlands, Luxembourg, Jersey and the Americas. Intertrust delivers high-quality, tailored corporate, fund, capital markets and private wealth services to its clients, with a view to building long-term relationships.   The Company works with global law firms and accountancy firms, multinational corporations, financial institutions, fund managers, high net worth individuals and family offices.

Ipsen is a global biopharmaceutical group focused on innovation and specialty care. The group develops and commercializes innovative medicines in three key therapeutic areas - Oncology, Neuroscience and Rare Diseases. Its commitment to Oncology is exemplified through its growing portfolio of key therapies for prostate cancer, neuroendocrine tumors, renal cell carcinoma and pancreatic cancer. Ipsen also has a well-established Consumer Healthcare business. With total sales over €1.9 billion in 2017, Ipsen sells more than 20 drugs in over 115 countries, with a direct commercial presence in more than 30 countries. For more information on Ipsen, visit www.ipsen.com.